FUJIFILM Corporation emite los comunicados de prensa en Japón.
Fujifilm no declara que los productos de estos comunicados de prensa estén disponibles comercialmente en todos los países y regiones.
Tenga en cuenta que el contenido de este sitio web está actualizado a la fecha del anuncio de prensa y puede estar sujeto a cambios sin previo aviso. La información de cada versión, incluida la disponibilidad de los productos, las especificaciones, los precios y los contactos, se corresponde con la del momento de la publicación.
- Ago 3, 2026
- Fujifilm and Taiho Pharmaceutical Enter into Strategic Partnership for Development of Next-Generation Antibody-Drug Conjugate (ADC) Manufacturing Technologies
- Jul 9, 2026
- FUJIFILM Biotechnologies Selected in FDA PreCheck Pilot Program to Advance U.S. Drug Manufacturing
- Jun 29, 2026
- Fujifilm and IAEA Sign Practical Arrangements to Strengthen Cancer Care through Medical Imaging Technology and Human Resource Development
- Jun 16, 2026
- Fujifilm and HORIBA Co-develop High-Sensitivity Inline Raman Measurement System for Real-Time Monitoring of Cell Culture and Purification in Biopharmaceutical Manufacturing
- May 20, 2026
- FUJIFILM Cellular Dynamics Launches New iPSC Manufacturing Facility in Madison
- Mar 12, 2026
- Fujifilm Invests in VALANX Biotech to Strengthen ADC CDMO Capabilities
- Feb 12, 2026
- FUJIFILM Biotechnologies Unveils Biomanufacturing and Process Development Expansion in the United Kingdom
- Dic 23, 2025
- Fujifilm Celebrates the Completion of One of the Japan’s Largest Bio CDMO Facilities in Toyama Prefecture
- Sep 25, 2025
- FUJIFILM Biotechnologies Celebrates the Grand Opening of its Commercial-Scale Cell Culture Manufacturing Site in North Carolina
- Sep 19, 2025
- FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations
- Abr 22, 2025
- FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-year U.S. Manufacturing Agreement Valued at Over $3 Billion
- Nov 5, 2024
- FUJIFILM Diosynth Biotechnologies Launches First Phase of Global CDMO Ecosystem Expansion
- Abr 12, 2024
- Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina
- Feb 29, 2024
- FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
- Dic 5, 2023
- Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities
- Nov 8, 2023
- FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility